Yang Yang

Yang Yang

Auto-generated profile, based on publicly available information

Yang Yang

Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences Peking University Beijing China

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
XYXin Ye
Xin Ye
MLMeiting Li
Meiting Li
THTianyun Hou
Tianyun Hou
TGTian Gao
Tian Gao
WZWei-Guo Zhu
Wei-Guo Zhu
YYYang Yang
Yang Yang
Sirtuins in glucose and lipid metabolism

7 October 2022 in Molecular Cell
Verified
Journal Article
Closed access
THTianyun Hou
Tianyun Hou
YTYuan Tian
Yuan Tian
ZCZiyang Cao
Ziyang Cao
JZJun Zhang
Jun Zhang
TFTingting Feng
Tingting Feng
WZWei-Guo Zhu
Wei-Guo Zhu

1 January 2021 in International Journal of Biological Sciences
Verified
Journal Article
Open access
SWShuo Wang
Shuo Wang
GMGuanqun Mu
Guanqun Mu
BQBingquan Qiu
Bingquan Qiu
MWMeng Wang
Meng Wang
ZYZunbo Yu
Zunbo Yu
YYYang Yang
Yang Yang
Crotonylation is a kind of newly discovered acylation modification. Thousands of crotonylation sites have been identified in histone and non-histone proteins over the past decade. As a modification closely related to acetylation, crotonylation was reported to share many universal enzymes with acetylation. Crotonylated proteins have important roles in the regulation of various biological processes, such as gene expression, process of spermatogenesis, cell cycle, and also in the pathogenesis of different diseases, which range from depression to cancer. In this review, we summarize the research processes of crotonylation and discuss the advances of regulation mechanism of both histone and non-histone proteins crotonylation in difference physiological processes. Also, we focus on the alteration of the crotonylation under certain pathological conditions and its role in the pathogenesis of each disease.

19 March 2019 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
WYWeili Yang
Weili Yang
BFBiaoqi Feng
Biaoqi Feng
YMYuhong Meng
Yuhong Meng
JWJunpei Wang
Junpei Wang
BGBin Geng
Bin Geng
JYJichun Yang
Jichun Yang
Family with sequence similarity three member C (FAM3C) (interleukin‐like EMT inducer [ILEI]), heat shock factor 1 (HSF1) and Ying‐Yang 1 (YY1) have been independently reported to be involved in the pathogenesis of various cancers. However, whether they are coordinated to trigger the development of cancer remains unknown. This study determined the role and mechanism of YY1 and HSF1 in FAM3C‐induced proliferation and migration of breast cancer cells. In human MDA‐MB‐231 breast cancer cell line, transforming growth factor‐β (TGFβ) up‐regulated FAM3C, HSF1 and YY1 expressions. FAM3C overexpression promoted the proliferation and migration of MDA‐MB‐231 cells with YY1 and HSF1 up‐regulation, whereas FAM3C silencing exerted the opposite effects. FAM3C inhibition repressed TGFβ‐induced HSF1 activation, and proliferation and migration of breast cancer cells. YY1 was shown to directly activate HSF1 transcription to promote the proliferation and migration of breast cancer cells. YY1 silencing blunted FAM3C‐ and TGFβ‐triggered activation of HSF1‐Akt‐Cyclin D1 pathway, and proliferation and migration of breast cancer cells. Inhibition of HSF1 blocked TGFβ‐, FAM3C‐ and YY1‐induced proliferation and migration of breast cancer cells. YY1 and HSF1 had little effect on FAM3C expression. Similarly, inhibition of HSF1 also blunted FAM3C‐ and TGFβ‐promoted proliferation and migration of human breast cancer BT‐549 cells. In human breast cancer tissues, FAM3C, YY1 and HSF1 protein expressions were increased. In conclusion, FAM3C activated YY1‐HSF1 signalling axis to promote the proliferation and migration of breast cancer cells. Furthermore, novel FAM3C‐YY1‐HSF1 pathway plays an important role in TGFβ‐triggered proliferation and migration of human breast cancer MDA‐MB‐231 cells.

1 January 2019 in Neoplasia
Verified
Journal Article
Open access
TGTian Gao
Tian Gao
MLMeiting Li
Meiting Li
GMGuanqun Mu
Guanqun Mu
THTianyun Hou
Tianyun Hou
WZWei-Guo Zhu
Wei-Guo Zhu
YYYang Yang
Yang Yang
Protein kinase C (PKC) has critical roles in regulating lipid anabolism and catabolism. PKCζ, a member of atypical PKC family, has been reported to mediate glucose metabolism. However, whether and how PKCζ regulates tumor cells fatty acid β-oxidation are unknown. Here, we report that the phosphorylation of SIRT6 is significantly increased after palmitic acid (PA) treatment in colon cancer cells. PKCζ can physically interact with SIRT6 in vitro and in vivo, and this interaction enhances following PA treatment. Further experiments show that PKCζ is the phosphorylase of SIRT6 and phosphorylates SIRT6 at threonine 294 residue to promote SIRT6 enrichment on chromatin. In the functional study, we find that the expression of ACSL1, CPT1, CACT, and HADHB, the genes related to fatty acid β-oxidation, increases after PA stimulation. We further confirm that PKCζ mediates the binding of SIRT6 specifically to the promoters of fatty acid β-oxidation-related genes and elicits the expression of these genes through SIRT6 phosphorylation. Our findings demonstrate the mechanism of PKCζ as a new phosphorylase of SIRT6 on maintaining tumor fatty acid β-oxidation and define the new role of PKCζ in lipid homeostasis.

20 September 2018 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
MLMeiting Li
Meiting Li
THTianyun Hou
Tianyun Hou
TGTian Gao
Tian Gao
XLXiaopeng Lu
Xiaopeng Lu
QYQiaoyan Yang
Qiaoyan Yang
WZWei-Guo Zhu
Wei-Guo Zhu
The tumor suppressor p53 has critical roles in regulating lipid metabolism, but whether and how p53 regulates cardiolipin (CL) de novo biosynthesis is unknown. Here, we report that p53 physically interacts with histone deacetylase SIRT6 in vitro and in vivo, and this interaction increases following palmitic acid (PA) treatment. In response to PA, p53 and SIRT6 localize to chromatin in a p53-dependent manner. Chromatin p53 and SIRT6 bind the promoters of CDP-diacylglycerol synthase 1 and 2 (CDS1 and CDS2), two enzymes required to catalyze CL de novo biosynthesis. Here, SIRT6 serves as a co-activator of p53 and effectively recruits RNA polymerase II to the CDS1 and CDS2 promoters to enhance CL de novo biosynthesis. Our findings reveal a novel, cooperative model executed by p53 and SIRT6 to maintain lipid homeostasis.